Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00002622
Other study ID # CALGB-9334
Secondary ID U10CA031946CLB-9
Status Completed
Phase Phase 3
First received November 1, 1999
Last updated June 27, 2016
Start date December 1994
Est. completion date January 2006

Study information

Verified date June 2016
Source Alliance for Clinical Trials in Oncology
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

RATIONALE: Talc may relieve malignant pleural effusion. It is not yet known whether wet talc is more effective than dry talc in treating patients with malignant pleural effusion.

PURPOSE: Randomized phase III trial to compare the effectiveness of wet talc with dry talc in treating patients with malignant pleural effusion.


Description:

OBJECTIVES: I. Compare the proportion of patients with successful pleurodesis at 30 days following treatment for malignant pleural effusion (MPE) by talc slurry via chest tube vs thoracoscopic talc insufflation. II. Compare the cost and cost effectiveness of both treatments for MPE. III. Compare the time to recurrence of effusion, duration of chest tube drainage after sclerosis, extent of postinstillation complications and toxicities, and the ability to re-expand the lung in patients randomized to these 2 treatments. IV. Evaluate the quality of life and pain experienced by patients during both treatments.

OUTLINE: This is a randomized study. Patients are stratified according to participating institution. Patients are randomized to one of two treatment arms. Arm I: Patients undergo pleurodesis. A chest tube is inserted, the pleural fluid is drained for 24 hours, and the lung is re-expanded to at least 90% of full expansion. Within 24-36 hours patients undergo sclerosis with talc slurry injected into the chest tube, which is then clamped. Patients are rotated in all possible directions, holding each position for about 30 minutes. After 2 hours the chest tube is unclamped and reattached to suction drainage, which is strictly measured for 24-hour totals. Following a decrease in drainage to no more than 150 ml/24 hours (usually by the second or third day postsclerosis), the chest tube is removed. Arm II: Patients receive thoracoscopic insufflation. The chest is explored thoracoscopically via single or multiple incisions using direct or videothoracoscopic visualization, and the lung is re-expanded to 90% of full expansion. Dry talc is pneumatically insufflated into the chest, with complete dispersion throughout the hemithorax. Following insufflation, the chest is drained via a chest tube, which is removed when the drainage is no more than 150 ml/24 hours (usually by day 2 or 3 following insufflation). Patients are removed from study for disease progression or an unsuccessful lung re-expansion. Patients are followed monthly for 6 months for relapse and survival.

PROJECTED ACCRUAL: Approximately 500 patients will be accrued for this study over 28 months.


Recruitment information / eligibility

Status Completed
Enrollment 501
Est. completion date January 2006
Est. primary completion date March 2005
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 120 Years
Eligibility DISEASE CHARACTERISTICS: Unilateral malignant pleural effusion requiring sclerosis (as judged by the attending surgeon) At least 3 months since treatment of contralateral effusion No chylous effusion

PATIENT CHARACTERISTICS: Age: 18 and over Performance status: ECOG 0-2 Life expectancy: More than 2 months Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Able to undergo thoracoscopy under general or local anesthesia (as determined by the attending surgeon) Not pregnant Tests and observations must be completed within 1 week prior to randomization (chest x-ray within 1 week prior to procedure)

PRIOR CONCURRENT THERAPY: No prior intrapleural therapy No systemic therapy within 2 weeks prior to randomization or 2 weeks post pleurodesis Biologic therapy: Not specified Chemotherapy: No new systemic chemotherapy for 2 weeks prior to and at least 2 weeks after pleurodesis Endocrine therapy: No new hormonal therapy for 2 weeks prior to and at least 2 weeks after pleurodesis No concurrent steroids used as antiemetics Radiotherapy: Prior radiotherapy allowed No radiotherapy to entire hemithorax Palliative irradiation of symptomatic bone lesions allowed on the affected side if field does not include a significant portion of pleura Surgery: See Disease Characteristics

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Drug:
talc
4 to 5 grams talc in 100 cc saline via chest tube at bedside, one time
Talc
4 to 5 grams talc via insufflation through direct or video thoracoscopy, one time

Locations

Country Name City State
Canada Tom Baker Cancer Center - Calgary Calgary Alberta
Canada Cross Cancer Institute Edmonton Alberta
Canada Nova Scotia Cancer Centre Halifax Nova Scotia
Canada Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton Ontario
Canada Kingston Regional Cancer Centre Kingston Ontario
Canada Cancer Care Ontario-London Regional Cancer Centre London Ontario
Canada Doctor Leon Richard Oncology Centre Moncton New Brunswick
Canada Centre Hospitalier de l'Universite de Montreal Montreal Quebec
Canada McGill University Department of Oncology Montreal Quebec
Canada Ottawa Regional Cancer Centre - Civic Campus Ottawa Ontario
Canada Saskatchewan Cancer Agency Regina Saskatchewan
Canada Saint John Regional Hospital Saint John New Brunswick
Canada Saskatoon Cancer Centre Saskatoon Saskatchewan
Canada Northeastern Ontario Regional Cancer Centre, Sudbury Sudbury Ontario
Canada Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay Ontario
Canada Princess Margaret Hospital Toronto Ontario
Canada British Columbia Cancer Agency - Vancouver Island Cancer Centre Victoria British Columbia
United States Akron City Hospital Akron Ohio
United States Akron General Medical Center Akron Ohio
United States Cancer Center of Albany Medical Center Albany New York
United States Veterans Affairs Medical Center - Albany Albany New York
United States Saint Joseph Medical Center Albuquerque New Mexico
United States Providence Cancer Therapy Center Anchorage Alaska
United States St. John's Medical Center Anderson Indiana
United States CCOP - Ann Arbor Regional Ann Arbor Michigan
United States University of Michigan Comprehensive Cancer Center Ann Arbor Michigan
United States Veterans Affairs Medical Center - Ann Arbor Ann Arbor Michigan
United States Anne Arundel Oncology Center Annapolis Maryland
United States CCOP - Atlanta Regional Atlanta Georgia
United States Emory University Hospital - Atlanta Atlanta Georgia
United States Greater Baltimore Medical Center and Cancer Center Baltimore Maryland
United States Harbor Hospital Center Baltimore Maryland
United States Johns Hopkins Oncology Center Baltimore Maryland
United States Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland
United States Radiation Oncology Affiliates of Maryland, P.A. Baltimore Maryland
United States Mary Bird Perkins Cancer Center Baton Rouge Louisiana
United States Julie and Ben Rogers Cancer Institute Beaumont Texas
United States CCOP - Montana Cancer Consortium Billings Montana
United States University of Alabama Comprehensive Cancer Center Birmingham Alabama
United States Veterans Affairs Medical Center - Birmingham Birmingham Alabama
United States Quain & Ramstad Clinic, P.C. Bismarck North Dakota
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States Joint Center for Radiation Therapy Boston Massachusetts
United States Massachusetts General Hospital Cancer Center Boston Massachusetts
United States Medical Center at Bowling Green Bowling Green Kentucky
United States Bridgeport Hospital Bridgeport Connecticut
United States Albert Einstein Comprehensive Cancer Center Bronx New York
United States New York Methodist Hospital Brooklyn New York
United States State University of New York Health Science Center at Brooklyn Brooklyn New York
United States Roswell Park Cancer Institute Buffalo New York
United States Providence Saint Joseph Medical Center - Burbank Burbank California
United States Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina
United States Medical University of South Carolina Charleston South Carolina
United States Cancer Center, University of Virginia HSC Charlottesville Virginia
United States Martha Jefferson Hospital Charlottesville Virginia
United States Northwestern Memorial Hospital Chicago Illinois
United States University of Chicago Cancer Research Center Chicago Illinois
United States Christ Hospital Cincinnati Ohio
United States Lykes Center for Radiation Therapy Clearwater Florida
United States Ireland Cancer Center Cleveland Ohio
United States Memorial Hospital Cancer Center Colorado Springs Colorado
United States Ellis Fischel Cancer Center - Columbia Columbia Missouri
United States Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio
United States CCOP - Columbus Columbus Ohio
United States Mount Diablo Medical Center Concord California
United States Samaritan Regional Cancer Center Corvallis Oregon
United States Penn State Geisinger Medical Center Danville Pennsylvania
United States Mercy Catholic Medical Center, Mercy Fitzgerald Divison Darby Pennsylvania
United States Veterans Affairs Medical Center - Dayton Dayton Ohio
United States Halifax Medical Center Daytona Beach Florida
United States University of Colorado Cancer Center Denver Colorado
United States CCOP - Iowa Oncology Research Association Des Moines Iowa
United States Barbara Ann Karmanos Cancer Institute Detroit Michigan
United States Henry Ford Hospital Detroit Michigan
United States Delaware County Memorial Hospital Drexel Hill Pennsylvania
United States Beckman Research Institute, City of Hope Duarte California
United States Wendt Regional Cancer Center of Finley Hospital Dubuque Iowa
United States CCOP - Duluth Duluth Minnesota
United States Veterans Affairs Medical Center - East Orange East Orange New Jersey
United States John F. Kennedy Medical Center Edison New Jersey
United States Elizabeth General Medical Center - West Elizabeth New Jersey
United States Meritcare Roger Maris Cancer Center Fargo North Dakota
United States Hurley Medical Center Flint Michigan
United States Radiation Therapy Associates - Fort Myers Fort Myers Florida
United States California Cancer Center Fresno California
United States Saint Agnes Cancer Center Fresno California
United States University of Florida Health Science Center Gainesville Florida
United States University of Texas Medical Branch Galveston Texas
United States Glendale Memorial Hospital and Health Center Glendale California
United States St. Vincent Hospital Green Bay Wisconsin
United States Sutter Health Western Division Cancer Research Group Greenbrae California
United States CCOP - Greenville Greenville South Carolina
United States East Carolina University School of Medicine Greenville North Carolina
United States CCOP - Northern New Jersey Hackensack New Jersey
United States Ingalls Memorial Hospital Harvey Illinois
United States Penn State Geisinger Cancer Center Hershey Pennsylvania
United States University of Texas - MD Anderson Cancer Center Houston Texas
United States Huntsville Hospital System Huntsville Alabama
United States Cape Cod Hospital Hyannis Massachusetts
United States Clarion Health Partners Inc. Indianapolis Indiana
United States Community Hospitals of Indianapolis - Regional Cancer Center Indianapolis Indiana
United States University of Iowa Hospitals and Clinics Iowa City Iowa
United States Jackson-Madison County General Hospital Jackson Tennessee
United States CCOP - Kalamazoo Kalamazoo Michigan
United States CCOP - Kansas City Kansas City Missouri
United States CCOP - Dayton Kettering Ohio
United States Baptist Regional Cancer Center - Knoxville Knoxville Tennessee
United States Gundersen Lutheran Medical Foundation La Crosse Wisconsin
United States Wilford Hall - 59th Medical Wing Lackland Air Force Base Texas
United States Romagosa Radiation Oncology Center Lafayette Louisiana
United States CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada
United States Norris Cotton Cancer Center Lebanon New Hampshire
United States Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky
United States Veterans Affairs Medical Center - Lexington Lexington Kentucky
United States Loma Linda University Medical Center Loma Linda California
United States Veterans Affairs Medical Center - Long Beach Long Beach California
United States Jonsson Comprehensive Cancer Center, UCLA Los Angeles California
United States Kaiser Permanente Medical Center - Los Angeles Los Angeles California
United States USC/Norris Comprehensive Cancer Center Los Angeles California
United States James Graham Brown Cancer Center Louisville Kentucky
United States Louisville Radiation Oncology Louisville Kentucky
United States Virginia Baptist Hospital Lynchburg Virginia
United States Southern Wisconsin Radiotherapy Center Madison Wisconsin
United States University of Wisconsin Comprehensive Cancer Center Madison Wisconsin
United States Veterans Affairs Medical Center - Madison Madison Wisconsin
United States Merle M. Mahr Cancer Center Madisonville Kentucky
United States Elliot Regional Cancer Center Manchester New Hampshire
United States CCOP - North Shore University Hospital Manhasset New York
United States Marquette General Hospital Marquette Michigan
United States Marshfield Clinic Marshfield Wisconsin
United States Veterans Affairs Outpatient Clinic - Martinez Martinez California
United States Loyola University Medical Center Maywood Illinois
United States Health First Holmes Regional Medical Center Melbourne Florida
United States CCOP - Baptist Cancer Institute Memphis Tennessee
United States University of Tennessee, Memphis Cancer Center Memphis Tennessee
United States Community Memorial Hospital Menomonee Falls Wisconsin
United States East Jefferson General Hospital Metairie Louisiana
United States Baptist Hospital of Miami Miami Florida
United States Sylvester Cancer Center, University of Miami Miami Florida
United States CCOP - Mount Sinai Medical Center Miami Beach Florida
United States South Jersey Hospital - Millville Millville New Jersey
United States Columbia Hospital Milwaukee Wisconsin
United States Medical College of Wisconsin Milwaukee Wisconsin
United States St. Joseph's Hospital Milwaukee Wisconsin
United States St. Luke's Medical Center Milwaukee Wisconsin
United States Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin
United States UNI-MED Medical Center Minot North Dakota
United States MBCCOP - University of South Alabama Mobile Alabama
United States Urology Associates - Mobile AL Mobile Alabama
United States Alabama Oncology, LLC Montgomery Alabama
United States Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County Mount Holly New Jersey
United States Ball Memorial Hospital Muncie Indiana
United States Vanderbilt Cancer Center Nashville Tennessee
United States CCOP - Ochsner New Orleans Louisiana
United States MBCCOP - LSU Medical Center New Orleans Louisiana
United States Kaplan Cancer Center New York New York
United States Memorial Sloan-Kettering Cancer Center New York New York
United States Whittingham Cancer Center Norwalk Connecticut
United States CCOP - Bay Area Tumor Institute Oakland California
United States CCOP - Missouri Valley Cancer Consortium Omaha Nebraska
United States Methodist Cancer Center - Omaha Omaha Nebraska
United States Florida Radiation Oncology Group Orange Park Florida
United States MD Anderson Cancer Center Orlando Orlando Florida
United States Western Baptist Hospital Paducah Kentucky
United States Gulf Coast Cancer Treatment Center Panama City Florida
United States Lutheran General Cancer Care Center Park Ridge Illinois
United States Bayshore Medical Center Pasadena Texas
United States West Florida Cancer Institute - Pensacola Pensacola Florida
United States Methodist Medical Center of Illinois Peoria Illinois
United States Albert Einstein Cancer Center Philadelphia Pennsylvania
United States Allegheny University Hospitals- Hahnemann Philadelphia Pennsylvania
United States Fox Chase Cancer Center Philadelphia Pennsylvania
United States Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania
United States University of Pennsylvania Cancer Center Philadelphia Pennsylvania
United States Veterans Affairs Medical Center - Philadelphia Philadelphia Pennsylvania
United States University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania
United States Western Pennsylvania Hospital Pittsburgh Pennsylvania
United States Champlain Valley Physicians Hospital Medical Center Plattsburgh New York
United States Cancer Care Center Pomona California
United States CCOP - Columbia River Program Portland Oregon
United States Maine Medical Center Portland Maine
United States Naval Medical Center, Portsmouth Portsmouth Virginia
United States Vassar Brothers Hospital Poughkeepsie New York
United States Southeastern Wisconsin Regional Cancer Center Racine Wisconsin
United States Rapid City Regional Hospital Rapid City South Dakota
United States Reading Hospital and Medical Center Reading Pennsylvania
United States Mercy Medical Center - Redding Redding California
United States Massey Cancer Center Richmond Virginia
United States Genesee Hospital - Rochester Rochester New York
United States Mayo Clinic Cancer Center Rochester Minnesota
United States University of Rochester Cancer Center Rochester New York
United States InterCommunity Cancer Center at Rome Rome Georgia
United States Green Mountain Oncology Group Rutland Vermont
United States Radiation Oncology Center - Sacramento Sacramento California
United States St. Mary's Medical Center Saginaw Michigan
United States Dixie Regional Medical Center Saint George Utah
United States Mallinckrodt Institute of Radiology Saint Louis Missouri
United States St. Louis University Health Sciences Center Saint Louis Missouri
United States Veterans Affairs Medical Center - Saint Louis Saint Louis Missouri
United States CCOP - Metro-Minnesota Saint Louis Park Minnesota
United States Bayfront Medical Center Saint Petersburg Florida
United States LDS Hospital Salt Lake City Utah
United States UCSF Cancer Center and Cancer Research Institute San Francisco California
United States Santa Cruz Radiation Oncology Medical Group, Inc. Santa Cruz California
United States CCOP - Santa Rosa Memorial Hospital Santa Rosa California
United States CCOP - Scottsdale Oncology Program Scottsdale Arizona
United States Mercy Hospital Cancer Center - Scranton Scranton Pennsylvania
United States Swedish Hospital Tumor Institute Seattle Washington
United States Virginia Mason Medical Center Seattle Washington
United States Grand View Hospital Sellersville Pennsylvania
United States Siouxland Hematology-Oncology Sioux City Iowa
United States Memorial Hospital of South Bend South Bend Indiana
United States St. Joseph's Radiation Oncology Center South Bend Indiana
United States CCOP - Upstate Carolina Spartanburg South Carolina
United States Deaconess Medical Center Spokane Washington
United States Cancer Research for the Ozarks Springfield Missouri
United States CCOP - Central Illinois Springfield Illinois
United States Stanford University Stanford California
United States H. Lee Moffitt Cancer Center and Research Institute Tampa Florida
United States CCOP - Toledo Community Hospital Oncology Program Toledo Ohio
United States Community Medical Center Toms River New Jersey
United States David Grant Medical Center Travis Air Force Base California
United States St. Francis Medical Center Trenton New Jersey
United States Arizona Cancer Center Tucson Arizona
United States St. John Medical Center Tulsa Oklahoma
United States Radiation Oncology Associates of West Alabama Tuscallosa Alabama
United States CCOP - Carle Cancer Center Urbana Illinois
United States South Georgia Medical Center Valdosta Georgia
United States New York Medical College Valhalla New York
United States Radiation Oncology Center - Walnut Creek Walnut Creek California
United States Walter Reed Army Medical Center Washington District of Columbia
United States Schiffler Oncology Center Wheeling West Virginia
United States Veterans Affairs Medical Center - White River Junction White River Junction Vermont
United States CCOP - Wichita Wichita Kansas
United States Wilkes Barre General Hospital Wilkes-Barre Pennsylvania
United States CCOP - Christiana Care Health Services Wilmington Delaware
United States CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina
United States Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem North Carolina
United States CCOP - MainLine Health Wynnewood Pennsylvania
United States Yakima Valley Memorial Hospital Yakima Washington
United States York Hospital York Pennsylvania

Sponsors (5)

Lead Sponsor Collaborator
Alliance for Clinical Trials in Oncology Eastern Cooperative Oncology Group, National Cancer Institute (NCI), North Central Cancer Treatment Group, Radiation Therapy Oncology Group

Countries where clinical trial is conducted

United States,  Canada, 

References & Publications (3)

Dresler CM, Herndon JE, Daniels T, et al.: Cancer and Leukemia Group B (CALGB) 9334: a phase III, intergroup study of sclerosis of malignant pleural effusion by talc. [Abstract] Proceedings of the American Society of Clinical Oncology 19: A2455, 2000.

Dresler CM, Olak J, Herndon JE 2nd, Richards WG, Scalzetti E, Fleishman SB, Kernstine KH, Demmy T, Jablons DM, Kohman L, Daniel TM, Haasler GB, Sugarbaker DJ; Cooperative Groups Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; North Centra — View Citation

Fleishman SB, Dresler C, Herndon JE, et al.: Quality of life (QOL) advantage of sclerosis for malignant pleural effusion (MPE) via talc thoracoscopy over chest tube infusion of talc slurry: a cancer and leukemia group B study. [Abstract] Proceedings of th

Outcome

Type Measure Description Time frame Safety issue
Primary Successful pleurodesis 30 days No
Primary Cost and cost effectiveness cost and cost effectiveness of treating malignant pleural effusions 30 days No
Secondary Time to recurrence of effusion 6 months No
Secondary Complications and toxicity 6 months Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Recruiting NCT05798611 - Study of ART0380 in Patients With Biologically Selected Solid Tumors Phase 2
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT05566574 - A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer Phase 1/Phase 2
Recruiting NCT05036681 - A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma Phase 2
Withdrawn NCT00005030 - SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver Phase 1
Recruiting NCT05525858 - KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
Recruiting NCT04085029 - Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Recruiting NCT06058988 - Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer Phase 2
Not yet recruiting NCT05981170 - Rurality Adapted Physical Activity Sport Health
Not yet recruiting NCT03058809 - Evaluation of Viatarâ„¢ Oncopheresis System in Removing CTC From Whole Blood Phase 1/Phase 2
Completed NCT02529553 - A Study of LY3076226 in Participants With Advanced or Metastatic Cancer Phase 1
Terminated NCT01929941 - An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies Phase 1
Completed NCT01302808 - Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Phase 1
Terminated NCT00918645 - Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis N/A
Completed NCT00795678 - Chemotherapeutic Agents in Brain/Breast N/A
Withdrawn NCT00769990 - Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases Phase 1/Phase 2
Completed NCT00557102 - Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung Phase 2
Recruiting NCT00398437 - Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer N/A